344
Participants
Start Date
February 28, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
December 31, 2009
Oral Satraplatin
The SPERA protocol states that satraplatin may be continued until evidence of disease progression (at the discretion of the investigator), intolerable toxicity, withdrawal of informed consent, or non compliance. The treatment consists of satraplatin 80 mg/m2 administered by mouth once daily for five consecutive days (days 1-5) plus prednison 5 mg po twice daily. The treatment cycle is repeated every 35 days.
Richmond University Medical Center, Staten Island
Hematology Oncology Assoc. of W. Suffolk, PC, Bay Shore
North Shore Hematology Oncology Assoc., East Setauket
The Mary Imogene Bassett Hospital, Cooperstown
Ephrata Cancer Center, Ephrata
Lancaster Cancer Center, Ltd., Lancaster
Greater Philadelphia Cancer Center, Philadelphia
Center for Cancer and Blood Disorders, Bethesda
Associates in Oncology/Hematology, Rockville
The Center for Clinical Research, Hagerstown
Peninsula Cancer Institute, Newport News
Virginia Oncology Associates, Newport News
Cancer Center of North Carolina, Raleigh
Gaston Hematology and Oncology, Gastonia
Carolina Health Care, Florence
GA Urology, Decatur
Suburban Hematology-Oncology Assoc., PC, Lawrenceville
Notheast Georgia Cancer Care, LLC, Athens
Medical Oncology Assoc. of Augusta, PC, Augusta
ICON, Jacksonville
Sacred Heart Hospital Cancer Research, Pensacola
Gainesville Hematology Oncology Associates, Gainesville
Mid-Florida Hematology & Oncology Centers, Orange City
MIMA Century Research Assoc., Melbourne
Marc I. Saltzman, Miami
Center for Hematology-Oncology, Boca Raton
Lakeland Regional Medical Center, Lakeland
Florida Cancer Care Specialists-Fort Myers Summerlin Office, Fort Myers
Florida Cancer Specialists, Port Charlotte
Florida Cancer Specalists, Bradenton
Ocala Oncology Center, Ocala
Urology Centers of Alabama, Homewood
Carraway Cancer Clinic, Birmingham
Birmingham Hematology and Oncology, Birmingham
McLeod Cancer and Blood Center, Johnson City
Kingsport Hematology Oncology, Kingsport
Boston Baskin Cancer Group D/B/A/ UTCI, Memphis
Mid-South Cancer Center, PC, Germantown
Mid-South Cancer Center, Germantown
The Jones Clinic, Germantown
NW MS Hem/Onc (Tupelo), Tupelo
Jackson Oncology Associates, Jackson
Drs.Caroll, Sheth and Raghavan, Louisville
Mid-Ohio Oncology/Hematology, Columbus
Hematology-Oncology Consultants, Inc, Columbus
Tricounty Hem/Onc Associates, Canton
Ohio Cancer Specialists, Mansfield
The Christ Hospital, Cincinnati
Mahendra M. Shah, MD, FACP, Hammond
Fort Wayne Medical Oncology Hematology, Inc., Fort Wayne
Kalamazoo Hematology and Oncology, Kalamazoo
Cancer & Hematology Centers of Western Michigan, Grand Rapids
McFarland Clinic PC, Ames
Cedar Valley Medical Specialists, Waterloo
Heartland Oncology & Hematology, LLP, Council Bluffs
Iowa Blood and Cancer Care, PLC, Cedar Rapids
Medical College of Wisconsin, Milwaukee
Green Bay Oncology, Ltd., Green Bay
MeritCare Clinical Research, Fargo
Trinity Cancer Care Center, Minot
The Billings Clinic, Billings
University of Chicago, Chicago
Medical & Surgical Spealists, LLC, Galesburg
Oncology Hematology Associates of Central IL, PC, Peoria
Mid-Illinois Hematology and Oncology Assoc., LTD, Normal
Urology Associates, S.C., Mattoon
St. Johns Mercy Medical Center, St Louis
The Center for Cancer Care & Research, St Louis
Columbia Comprehensive Cancer Care Center, Columbia
Ellis Fischel Cancer Center, Columbia
Nebraska Hematology-Oncology,PC, Lincoln
Saint Francis Memoiral Hospital, Grand Island
Mary Bird Perkins Cancer Center, Baton Rouge
Genesis Cancer Center, Hot Springs
Clopton Clinic, Jonesboro
Cancer Care Associates, Oklahoma City
Cancer Specialists of Oklahoma, Oklahoma City
Cancer Care Associates, Tulsa
Center for Oncology Research and Treatment, Dallas
Texas Oncology, Dallas
Clinical Oncology & Hematology, LLP, Dallas
Dallas Oncology Consultants, PA, Dallas
Mitchell Medical Clinic, Daingerfield
Texas Cancer Center, Denton
Cancer Care Centers of South Texas, New Braunfels
Coastal Bend Cancer Center, Corpus Christi
Cancer Care Centers of South Texas, Fredericksburg
Texas Oncology Cancer Center, PA, Austin
Lone Star Oncology Consultants, Austin
Harrington Cancer Center, Amarillo
Allison Cancer Center, Midland
Rocky Mountain Cancer Center, Colorado Springs
Northern Utah Associates, Ogden
Pacific Shores Medical Group, Long Beach
North Valley Hematology/Oncology Medical Group, Mission Hills
East Valley Hematology Oncology Medical Group, Burbank
Sharp Clinical Oncology Research, San Diego
Desert Cancer Center, Rancho Mirage
Newport Cancer Care Medical Assoc., Inc., Newport Beach
Michael Harris MD, Mission Viejo
Pacific Cancer Medical Center, Inc, Anaheim
Medical Oncology Care Associates, Orange
Santa Barbara Hematology Oncology Medical Group, Santa Barbara
Santa Barbara Hemotology, Santa Barbara
Pacific Hematology Oncology Associates, San Francisco
Stockton Hematology Oncology Medical Group, Stockton
Sierra Nevada Oncology, Truckee
Northwest Cancer Specialists, PC, Vancouver
Sacred Heart Medical Center - Providence Cancer Care Center, Spokane
Providence Alaska Medical Center, Anchorage
Oncology Associates of Bridgeport, Bridgeport
Medical Specialists of Fairfield, LLC, Fairfield
Davis, Posteraro, and Wasser, MDs, LLP, Manchester
Whittigham Cancer Center at Norwalk Hospital, Norwalk
Eastern Connecticut Hematology and Oncology Associates, Norwich
Hematology Oncology, Stamford
Connecticut Oncology & Hematology, LLP, Torrington
Lahey Clinic, Burlington
Cancer Care at St. Claire's, Denville
Hematology Oncology Associates of Northern New Jersey, Morristown
Northern Valley Medical, Westwood
Lead Sponsor
Agennix
INDUSTRY